New compound N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-3-pyrazole carboxamide useful as a cannabinoid receptor antagonist, e.g. for treating eating disorders, obesity, amnesia and cognitive disorders

摘要

N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-3-pyrazole carboxamide (I) is new. N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-3-pyrazo lecarboxamide of formula (I) and its salts and solvates are new: An Independent claim is also included for a process for preparing (I).